“…The gene expression results in P(BF+AOx) treated samples in the jejunum did not show any significant differences in IL-6 expression ( Table 11 ). Because gp130 is stimulated by ligands other than IL-6, the phosphorylation of gp130 receptor as observed in the kinome peptide array results indicate metabolic downstream signaling via this receptor in P(BF+AOx) jejunum ( Bortoluzzi et al, 2021 ). Thus, the immunometabolic effects of P(BF+AOx) is strongly dependent on signaling via the immunomodulatory cytokine receptor, IL-6R.…”